NovaBay Pharmaceuticals, Inc.·4

Oct 12, 4:38 PM ET

Khosrovi Behzad 4

4 · NovaBay Pharmaceuticals, Inc. · Filed Oct 12, 2012

Insider Transaction Report

Form 4
Period: 2012-10-10
Khosrovi Behzad
VP Research and Development
Transactions
  • Award

    Option (right to buy)

    2012-10-10+25,000511,283 total
    Exercise: $1.29From: 2013-10-10Exp: 2022-10-10Common Stock (25,000 underlying)

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    PRIMARY DOCUMENT